Analysis of Default Risk in Microfinance Institutions under The Basel III Framework
Metadata
Show full item recordEditorial
Wiley
Date
2023Referencia bibliográfica
Durango‐Gutiérrez, M. P., Lara‐Rubio, J., & Navarro‐Galera, A. (2023). Analysis of default risk in microfinance institutions under the Basel III framework. International Journal of Finance & Economics, 28(2), 1261-1278
Abstract
International organisations such as OECD, WBG, IMF, UN and EU, as well as research studies, have highlighted the increasing contribution being made by microcredit institutions (MFIs) to financial inclusion, sustainable economic development and the fight against poverty. However, access to MFI credit is still far from the desired level for small and micro-enterprises, especially in developing countries. The countries of Latin America and the Caribbean, where approximately half of small formal companies do not have access to credit, have the world’s highest financial gap ratio compared to potential demand (87%). In this context, effective instruments are needed to assess default risk, through credit ratings. Based on the Basel III regulations, an empirical study was conducted of two microcredit portfolios corresponding to two MFIs in two Latin American countries (Bolivia and Colombia) during the period 2012-2015, to identify the explanatory variables of the probability of default on loans granted by MFIs, using a logistic regression model and a neural network. The results obtained show that the main variables in this respect are the amount of the loan, the number of payments in arrears, the guarantees provided, the assessment of the credit analyst, male gender of the borrower and the level and trend of the general stock exchange index. The conclusions presented advance previous research findings and may be useful for MFI managers, regulatory institutions, financial analysts, scholars, policy-makers and applicants for microcredits to undertake a business project, especially in times of emerging crisis, such as that caused by the Covid-19 pandemic.